Treating the dysfunctional placenta

Journal of Endocrinology

Volumn 234, Issue 2, 2017, Pages R81-R97

  Sibley, Colin P ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Dysfunction; Fetal growth restriction; Placenta; Pre eclampsia; Treatment

Indexed keywords

ADENOVIRUS VECTOR; CHOLESTEROL; HEME OXYGENASE; NANOPARTICLE; SILDENAFIL; SOMATOMEDIN B; VASCULOTROPIN;

CHOLESTEROL SYNTHESIS; HUMAN; IN VITRO STUDY; NONHUMAN; PATHOPHYSIOLOGY; PLACENTA CIRCULATION; PLACENTA DISORDER; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; FEMALE; FETAL GROWTH RETARDATION; PLACENTA DISEASES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME;

FEMALE; FETAL GROWTH RETARDATION; HUMANS; PLACENTA DISEASES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME;

EID: 85029667879     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-17-0185     Document Type: Review

References (96)

1. Alers NO, Jenkin G, Miller SL & Wallace EM 2013 Antenatal melatonin as an antioxidant in human pregnancies complicated by fetal growth restriction - a phase I pilot clinical trial: study protocol. BMJ Open 3 e004141. (doi:10.1136/bmjopen-2013-004141)
2. Balan A, Szaingurten-Solodkin I, Swissa SS, Feinshtein V, Huleihel M, Holcberg G, Dukler D & Beharier O 2017 The effects of pravastatin on the normal human placenta: Lessons from ex-vivo models. PLoS ONE 12 e0172174. (doi:10.1371/journal.pone.0172174)
3. Baschat AB & Galan HL 2017 Intrauteine growth restriction. In Obstetrics: Normal and Problem Pregnancies, edn 7th, pp 737-769. Eds SG Gabbe, JR Niebyl, JL Simpson, MB Landon, HL Galan, ERM Jauniaux, DA Driscoll, V Berghella & WA Grobman. Philadelphia, PA, USA: Elsevier.
4. Benton SJ, McCowan LM, Heazell AE, Grynspan D, Hutcheon JA, Senger C, Burke O, Chan Y, Harding JE, Yockell-Lelièvre J, et al. 2016 Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction. Placenta 42 1-8. (doi:10.1016/j.placenta.2016.03.010)
5. Brien ME, Duval C, Palacios J, Boufaied I, Hudon-Thibeault AA, Nadeau-Vallée M, Vaillancourt C, Sibley CP, Abrahams VM, Jones RL, et al. 2017 Uric acid crystals induce placental inflammation and alter trophoblast function via an IL-1-dependent pathway: implications for fetal growth restriction. Journal of Immunology 198 443-451. (doi:10.4049/jimmunol.1601179)
6. Brosens I, Pijnenborg R, Vercruysse L & Romero R 2011 The 'Great Obstetrical Syndromes' are associated with disorders of deep placentation. American Journal of Obstetrics and Gynecology 204 193-201. (doi:10.1016/j.ajog.2010.08.009)
7. Brownbill P, Edwards D, Jones C, Mahendran D, Owen D, Sibley C, Johnson R, Swanson P & Nelson DM 1995 Mechanisms of alphafetoprotein transfer in the perfused human placental cotyledon from uncomplicated pregnancy. Journal of Clinical Investigation 96 2220-2226. (doi:10.1172/JCI118277)
8. Brownbill P, Desforges M, Sebire N, Greenwood SL, Sibley CP & David AL 2014 Human placental ex vivo studies to support an adenovirus-mediated vascular endothelial growth factor (VEGF) gene medicine for the treatment of severe early onset fetal growth restriction (FGR). Human Gene Therapy 25 A60.
9. Brownfoot FC, Tong S, Hannan NJ, Binder NK, Walker SP, Cannon P, Hastie R, Onda K & Kaitu'u-Lino TJ 2015 Effects of pravastatin on human placenta, endothelium, and women with severe preeclampsia. Hypertension 66 687-697; discussion 445. (doi:10.1161/HYPERTENSIONAHA.115.05445)
10. Brownfoot FC, Tong S, Hannan NJ, Hastie R, Cannon P, Tuohey L & Kaitu'u-Lino TJ 2015 YC-1 reduces placental sFlt-1 and soluble endoglin production and decreases endothelial dysfunction: a possible therapeutic for preeclampsia. Molecular and Cellular Endocrinology 413 202-208. (doi:10.1016/j.mce.2015.06.033)
11. Brownfoot FC, Hastie R, Hannan NJ, Cannon P, Tuohey L, Parry LJ, Senadheera S, Illanes SE, Kaitu'u-Lino TJ & Tong S 2016 Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction. American Journal of Obstetrics and Gynecology 214 356.e301-356.e315. (doi:10.1016/j.ajog.2015.12.019)
12. Brownfoot FC, Tong S, Hannan NJ, Hastie R, Cannon P & Kaitu'u-Lino TJ 2016 Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta. BMC Pregnancy and Childbirth 16 117. (doi:10.1186/s12884-016-0902-3)
13. Burton GJ, Sibley CP & Jauniaux ERM 2017 Placental anatomy and physiology. In Obstetrics: Normal and Problem Pregnancies, edn 7th, pp 2-25. Eds SG Gabbe, JR Niebyl, JL Simpson, MB Landon, HL Galan, ERM Jauniaux, DA Driscoll, V Berghella & WA Grobman. Philadelphia, PA, USA: Elsevier.
14. Carr DJ, Wallace JM, Aitken RP, Milne JS, Mehta V, Martin JF, Zachary IC, Peebles DM & David AL 2014 Uteroplacental adenovirus vascular endothelial growth factor gene therapy increases fetal growth velocity in growth-restricted sheep pregnancies. Human Gene Therapy 25 375-384. (doi:10.1089/hum.2013.214)
15. Carr DJ, Wallace JM, Aitken RP, Milne JS, Martin JF, Zachary IC, Peebles DM & David AL 2016 Peri- and postnatal effects of prenatal adenoviral VEGF gene therapy in growth-restricted sheep. Biology of Reproduction 94 142. (doi:10.1095/biolreprod.115.133744)
16. Chappell LC & David AL 2016 Improving the pipeline for developing and testing pharmacological treatments in pregnancy. PLoS Medicine 13 e1002161. (doi:10.1371/journal.pmed.1002161)
17. Charnock JC, Dilworth MR, Aplin JD, Sibley CP, Westwood M & Crocker IP 2016 The impact of a human IGF-II analog ([Leu27]IGF-II) on fetal growth in a mouse model of fetal growth restriction. American Journal of Physiology: Endocrinology and Metabolism 310 E24-E31. (doi:10.1152/ajpendo.00379.2015)
18. Chen YH, Xu DX, Wang JP, Wang H, Wei LZ, Sun MF & Wei W 2006 Melatonin protects against lipopolysaccharide-induced intra-uterine fetal death and growth retardation in mice. Journal of Pineal Research 40 40-47. (doi:10.1111/j.1600-079X.2005.00274.x)
19. Chen B, Tuuli MG, Longtine MS, Shin JS, Lawrence R, Inder T & Michael Nelson D 2012 Pomegranate juice and punicalagin attenuate oxidative stress and apoptosis in human placenta and in human placental trophoblasts. American Journal of Physiology: Endocrinology and Metabolism 302 E1142-E1152. (doi:10.1152/ajpendo.00003.2012)
20. Chen B, Longtine MS & Nelson DM 2013 Punicalagin, a polyphenol in pomegranate juice, downregulates p53 and attenuates hypoxia-induced apoptosis in cultured human placental syncytiotrophoblasts. American Journal of Physiology: Endocrinology and Metabolism 305 E1274-E1280. (doi:10.1152/ajpcell.00242.2013)
21. Choudhary R, Desai K, Parekh H & Ganla K 2016 Sildenafil citrate for the management of fetal growth restriction and oligohydramnios. International Journal of Women's Health 8 367-372. (doi:10.2147/ijwh.s108370)
22. Constância M, Hemberger M, Hughes J, Dean W, Ferguson-Smith A, Fundele R, Stewart F, Kelsey G, Fowden A, Sibley C, et al. 2002 Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 417 945-948. (doi:10.1038/nature00819)
23. Constância M, Angiolini E, Sandovici I, Smith P, Smith R, Kelsey G, Dean W, Ferguson-Smith A, Sibley CP, Reik W, et al. 2005 Adaptation of nutrient supply to fetal demand in the mouse involves interaction between the Igf2 gene and placental transporter systems. PNAS 102 19219-19224. (doi:10.1073/pnas.0504468103)
24. Costa MA 2016 The endocrine function of human placenta: an overview. Reproductive BioMedicine Online 32 14-43. (doi:10.1016/j.rbmo.2015.10.005)
25. Costantine MM, Cleary K, Hebert MF, Ahmed MS, Brown LM, Ren Z, Easterling TR, Haas DM, Haneline LS, Caritis SN, et al. 2016 Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial. American Journal of Obstetrics and Gynecology 214 720.e701-720.e717. (doi:10.1016/j.ajog.2015.12.038)
26. David AL, Torondel B, Zachary I, Wigley V, Abi-Nader K, Nader KA, Mehta V, Buckley SM, Cook T, Boyd M, et al. 2008 Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep. Gene Therapy 15 1344-1350. (doi:10.1038/gt.2008.102)
27. Desforges M & Sibley CP 2010 Placental nutrient supply and fetal growth. International Journal of Developmental Biology 54 377-390. (doi:10.1387/ijdb.082765md)
28. Dilworth MR & Sibley CP 2013 Review: transport across the placenta of mice and women. Placenta 34 (Supplement) S34-S39. (doi:10.1016/j.placenta.2012.10.011)
29. Dilworth MR, Kusinski LC, Cowley E, Ward BS, Husain SM, Constância M, Sibley CP & Glazier JD 2010 Placental-specific Igf2 knockout mice exhibit hypocalcemia and adaptive changes in placental calcium transport. PNAS 107 3894-3899. (doi:10.1073/pnas.0911710107)
30. Dilworth MR, Kusinski LC, Baker BC, Renshall LJ, Greenwood SL, Sibley CP & Wareing M 2011 Defining fetal growth restriction in mice: a standardized and clinically relevant approach. Placenta 32 914-916. (doi:10.1016/j.placenta.2011.08.007)
31. Dilworth MR, Andersson I, Renshall LJ, Cowley E, Baker P, Greenwood S, Sibley CP & Wareing M 2013 Sildenafil citrate increases fetal weight in a mouse model of fetal growth restriction with a normal vascular phenotype. PLoS ONE 8 e77748. (doi:10.1371/journal.pone.0077748)
32. Doridot L, Passet B, Méhats C, Rigourd V, Barbaux S, Ducat A, Mondon F, Vilotte M, Castille J, Breuiller-Fouché M, et al. 2013 Preeclampsia-like symptoms induced in mice by fetoplacental expression of STOX1 are reversed by aspirin treatment. Hypertension 61 662-668. (doi:10.1161/HYPERTENSIONAHA.111.202994)
33. Duley L 2009 The global impact of pre-eclampsia and eclampsia. Seminars in Perinatology 33 130-137. (doi:10.1053/j.semperi.2009.02.010)
34. El-Sayed MA, Saleh SA, Maher MA & Khidre AM 2017 Utero-placental perfusion Doppler indices in growth restricted fetuses: effect of sildenafil citrate. Journal of Maternal-Fetal and Neonatal Medicine 1-6. (doi:10.1080/14767058.2017.1306509)
35. Erlandsson L, Nääv Å, Hennessy A, Vaiman D, Gram M, Åkerström B & Hansson SR 2016 Inventory of novel animal models addressing etiology of preeclampsia in the development of new therapeutic/intervention opportunities. American Journal of Reproductive Immunology 75 402-410. (doi:10.1111/aji.12460)
36. Fisk NM & Atun R 2008 Market failure and the poverty of new drugs in maternal health. PLoS Medicine 5 e22. (doi:10.1371/journal.pmed.0050022)
37. Flenady V, Koopmans L, Middleton P, Frøen JF, Smith GC, Gibbons K, Coory M, Gordon A, Ellwood D, McIntyre HD, et al. 2011 Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet 377 1331-1340. (doi:10.1016/S0140-6736(10)62233-7)
38. Forbes K, Hurst LM, Aplin JD, Westwood M & Gibson JM 2008 Statins are detrimental to human placental development and function; use of statins during early pregnancy is inadvisable. Journal of Cellular and Molecular Medicine 12 2295-2296. (doi:10.1111/j.1582-4934.2008.00466.x)
39. Forbes K, Shah VK, Siddals K, Gibson JM, Aplin JD & Westwood M 2015 Statins inhibit insulin-like growth factor action in first trimester placenta by altering insulin-like growth factor 1 receptor glycosylation. Molecular Human Reproduction 21 105-114. (doi:10.1093/molehr/gau093)
40. Franks ME, Macpherson GR & Figg WD 2004 Thalidomide. Lancet 363 1802-1811. (doi:10.1016/S0140-6736(04)16308-3)
41. Ganzevoort W, Alfirevic Z, von Dadelszen P, Kenny L, Papageorghiou A, van Wassenaer-Leemhuis A, Gluud C, Mol BW & Baker PN 2014 STRIDER: sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction - a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis. Systematic Reviews 3 23. (doi:10.1186/2046-4053-3-23)
42. González-Candia A, Veliz M, Araya C, Quezada S, Ebensperger G, Serón-Ferré M, Reyes RV, Llanos AJ & Herrera EA 2016 Potential adverse effects of antenatal melatonin as a treatment for intrauterine growth restriction: findings in pregnant sheep. American Journal of Obstetrics and Gynecology 215 245.e241-245.e247. (doi:10.1016/j.ajog.2016.02.040)
43. Greenwood SL & Sibley CP 2006 In vitro methods for studying human placental amino acid transport:placental villous fragments. In Placenta and Trophoblast: Methods and Protocols, pp 253-264. Eds MJ Soares & JS Hunt. New Jersey, NJ, USA: Humana Press.
44. Heazell AE, Siassakos D, Blencowe H, Burden C, Bhutta ZA, Cacciatore J, Dang N, Das J, Flenady V, Gold KJ, et al. 2016 Stillbirths: economic and psychosocial consequences. Lancet 387 604-616. (doi:10.1016/S0140-6736(15)00836-3)
45. Hefler LA, Reyes CA, O'Brien WE & Gregg AR 2001 Perinatal development of endothelial nitric oxide synthase-deficient mice. Biology of Reproduction 64 666-673. (doi:10.1095/biolreprod64.2.666)
46. Hobson SR, Lim R, Gardiner EE, Alers NO & Wallace EM 2013 Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by pre-eclampsia (PAMPR): study protocol. BMJ Open 3 e003788. (doi:10.1136/bmjopen-2013-003788)
47. Hoffmann DS, Weydert CJ, Lazartigues E, Kutschke WJ, Kienzle MF, Leach JE, Sharma JA, Sharma RV & Davisson RL 2008 Chronic tempol prevents hypertension, proteinuria, and poor feto-placental outcomes in BPH/5 mouse model of preeclampsia. Hypertension 51 1058-1065. (doi:10.1161/HYPERTENSIONAHA.107.107219)
48. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA & Fishman MC 1995 Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377 239-242. (doi:10.1038/377239a0)
49. Jones S, Bischof H, Lang I, Desoye G, Greenwood SL, Johnstone ED, Wareing M, Sibley CP & Brownbill P 2015 Dysregulated flow-mediated vasodilatation in the human placenta in fetal growth restriction. Journal of Physiology 593 3077-3092. (doi:10.1113/JP270495)
50. Kanasaki K, Palmsten K, Sugimoto H, Ahmad S, Hamano Y, Xie L, Parry S, Augustin HG, Gattone VH, Folkman J, et al. 2008 Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature 453 1117-1121. (doi:10.1038/nature06951)
51. King A, Ndifon C, Lui S, Widdows K, Kotamraju VR, Agemy L, Teesalu T, Glazier JD, Cellesi F, Tirelli N, et al. 2016 Tumor-homing peptides as tools for targeted delivery of payloads to the placenta. Science Advances 2 e1600349. (doi:10.1126/sciadv.1600349)
52. Kliman HJ, Nestler JE, Sermasi E, Sanger JM & Strauss JF 1986 Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 118 1567-1582. (doi:10.1210/endo-118-4-1567)
53. Kulandavelu S, Whiteley KJ, Qu D, Mu J, Bainbridge SA & Adamson SL 2012 Endothelial nitric oxide synthase deficiency reduces uterine blood flow, spiral artery elongation, and placental oxygenation in pregnant mice. Hypertension 60 231-238. (doi:10.1161/HYPERTENSIONAHA.111.187559)
54. Kulandavelu S, Whiteley KJ, Bainbridge SA, Qu D & Adamson SL 2013 Endothelial NO synthase augments fetoplacental blood flow, placental vascularization, and fetal growth in mice. Hypertension 61 259-266. (doi:10.1161/HYPERTENSIONAHA.112.201996)
55. Kumasawa K, Ikawa M, Kidoya H, Hasuwa H, Saito-Fujita T, Morioka Y, Takakura N, Kimura T & Okabe M 2011 Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model. PNAS 108 1451-1455. (doi:10.1073/pnas.1011293108)
56. Kusinski LC, Dilworth MR, Baker PN, Sibley CP, Wareing M & Glazier JD 2011 System A activity and vascular function in the placental-specific Igf2 knockout mouse. Placenta 32 871-876. (doi:10.1016/j.placenta.2011.07.086)
57. Kusinski LC, Stanley JL, Dilworth MR, Hirt CJ, Andersson IJ, Renshall LJ, Baker BC, Baker PN, Sibley CP, Wareing M, et al. 2012 eNOS knockout mouse as a model of fetal growth restriction with an impaired uterine artery function and placental transport phenotype. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 303 R86-R93. (doi:10.1152/ajpregu.00600.2011)
58. Lemley CO, Meyer AM, Camacho LE, Neville TL, Newman DJ, Caton JS & Vonnahme KA 2012 Melatonin supplementation alters uteroplacental hemodynamics and fetal development in an ovine model of intrauterine growth restriction. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 302 R454-R467. (doi:10.1152/ajpregu.00407.2011)
59. Lemley CO, Camacho LE & Vonnahme KA 2013 Uterine infusion of melatonin or melatonin receptor antagonist alters ovine feto-placental hemodynamics during midgestation. Biology of Reproduction 89 40.
60. López-Tello J, Arias-álvarez M, Jiménez-Martínez M, Barbero-Fernández A, García-García RM, Rodríguez M, Lorenzo PL, Torres-Rovira L, Astiz S, González-Bulnes A, et al. 2016 The effects of sildenafil citrate on feto? Placental development and haemodynamics in a rabbit model of intrauterine growth restriction. Reproduction, Fertility, and Development [in press]. (doi:10.1071/RD1533)
61. McCarthy FP, Kingdom JC, Kenny LC & Walsh SK 2011 Animal models of preeclampsia; uses and limitations. Placenta 32 413-419. (doi:10.1016/j.placenta.2011.03.010)
62. Mehta V, Abi-Nader KN, Peebles DM, Benjamin E, Wigley V, Torondel B, Filippi E, Shaw SW, Boyd M, Martin J, et al. 2012 Long-term increase in uterine blood flow is achieved by local overexpression of VEGF-A(165) in the uterine arteries of pregnant sheep. Gene Therapy 19 925-935. (doi:10.1038/gt.2011.158)
63. Mehta V, Ofir K, Swanson A, Kloczko E, Boyd M, Barker H, Avdic-Belltheus A, Martin J, Zachary I, Peebles D, et al. 2016 Gene targeting to the uteroplacental circulation of pregnant guinea pigs. Reproductive Sciences 23 1087-1095. (doi:10.1177/1933719116630411)
64. Miller SL, Loose JM, Jenkin G & Wallace EM 2009 The effects of sildenafil citrate (Viagra) on uterine blood flow and well being in the intrauterine growth-restricted fetus. American Journal of Obstetrics and Gynecology 200 102.e101-102.e107.
65. Nadeau-Vallée M, Obari D, Palacios J, Brien M, Duval C, Chemtob S & Girard S 2016 Sterile inflammation and pregnancy complications: a review. Reproduction 152 R277-R292.
66. Nagai R, Watanabe K, Wakatsuki A, Hamada F, Shinohara K, Hayashi Y, Imamura R & Fukaya T 2008 Melatonin preserves fetal growth in rats by protecting against ischemia/reperfusion-induced oxidative/nitrosative mitochondrial damage in the placenta. Journal of Pineal Research 45 271-276. (doi:10.1111/j.1600-079X.2008.00586.x)
67. Nassar AH, Masrouha KZ, Itani H, Nader KA & Usta IM 2012 Effects of sildenafil in N?-nitro-L-arginine methyl ester-induced intrauterine growth restriction in a rat model. American Journal of Perinatology 29 429-434. (doi:10.1055/s-0032-1304823)
68. Onda K, Tong S, Nakahara A, Kondo M, Monchusho H, Hirano T, Kaitu'u-Lino T, Beard S, Binder N, Tuohey L, et al. 2015 Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsia. Hypertension 65 855-862. (doi:10.1161/HYPERTENSIONAHA.114.04781)
69. Onda K, Tong S, Beard S, Binder N, Muto M, Senadheera SN, Parry L, Dilworth M, Renshall L, Brownfoot F, et al. 2017 Proton pump inhibitors decrease soluble fms-like tyrosine kinase-1 and soluble endoglin secretion, decrease hypertension, and rescue endothelial dysfunction. Hypertension 69 457-468. (doi:10.1161/HYPERTENSIONAHA.116.08408)
70. Oyston C, Stanley JL, Oliver MH, Bloomfield FH & Baker PN 2016 Maternal administration of sildenafil citrate alters fetal and placental growth and fetal-placental vascular resistance in the growth-restricted ovine fetus. Hypertension 68 760-767. (doi:10.1161/HYPERTENSIONAHA.116.07662)
71. Panda S, Das A & Md Nowroz H 2014 Sildenafil citrate in fetal growth restriction. Journal of Reproduction and Infertility 15 168-169.
72. Panitchob N, Widdows KL, Crocker IP, Johnstone ED, Please CP, Sibley CP, Glazier JD, Lewis RM & Sengers BG 2016 Computational modelling of placental amino acid transfer as an integrated system. Biochimica et Biophysica Acta 1858 1451-1461. (doi:10.1016/j.bbamem.2016.03.028)
73. Poudel R, Stanley JL, Rueda-Clausen CF, Andersson IJ, Sibley CP, Davidge ST & Baker PN 2013 Effects of resveratrol in pregnancy using murine models with reduced blood supply to the uterus. PLoS ONE 8 e64401. (doi:10.1371/journal.pone.0064401)
74. Powe CE, Levine RJ & Karumanchi SA 2011 Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 123 2856-2869. (doi:10.1161/CIRCULATIONAHA.109.853127)
75. Richter HG, Hansell JA, Raut S & Giussani DA 2009 Melatonin improves placental efficiency and birth weight and increases the placental expression of antioxidant enzymes in undernourished pregnancy. Journal of Pineal Research 46 357-364. (doi:10.1111/j.1600-079X.2009.00671.x)
76. Saad AF, Kechichian T, Yin H, Sbrana E, Longo M, Wen M, Tamayo E, Hankins GD, Saade GR & Costantine MM 2014 Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia. Reproductive Sciences 21 138-145. (doi:10.1177/1933719113492207)
77. Sakamoto M, Osato K, Kubo M, Nii M, Tanaka H, Murabayashi N, Umekawa T, Kamimoto Y & Ikeda T 2016 Early-onset fetal growth restriction treated with the long-acting phosphodiesterase-5 inhibitor tadalafil: a case report. Journal of Medical Case Reports 10 317. (doi:10.1186/s13256-016-1098-x)
78. Satterfield MC, Bazer FW, Spencer TE & Wu G 2010 Sildenafil citrate treatment enhances amino acid availability in the conceptus and fetal growth in an ovine model of intrauterine growth restriction. Journal of Nutrition 140 251-258. (doi:10.3945/jn.109.114678)
79. Schneider H, Panigel M & Dancis J 1972 Transfer across the perfused human placenta of antipyrine, sodium and leucine. American Journal of Obstetrics and Gynecology 114 822-828. (doi:10.1016/0002-9378(72)90909-X)
80. Sferruzzi-Perri AN & Camm EJ 2016 The programming power of the placenta. Frontiers in Physiology 7 33. (doi:10.3389/fphys.2016.00033)
81. Sheppard M, Spencer RN, Ashcroft R, David AL & Consortium E 2016 Ethics and social acceptability of a proposed clinical trial using maternal gene therapy to treat severe early-onset fetal growth restriction. Ultrasound in Obstetrics and Gynecology 47 484-491. (doi:10.1002/uog.15880)
82. Sibley CP, Coan PM, Ferguson-Smith AC, Dean W, Hughes J, Smith P, Reik W, Burton GJ, Fowden AL & Constância M 2004 Placental-specific insulin-like growth factor 2 (Igf2) regulates the diffusional exchange characteristics of the mouse placenta. PNAS 101 8204-8208. (doi:10.1073/pnas.0402508101)
83. Sibley CP, Turner MA, Cetin I, Ayuk P, Boyd CA, D'Souza SW, Glazier JD, Greenwood SL, Jansson T & Powell T 2005 Placental phenotypes of intrauterine growth. Pediatric Research 58 827-832. (doi:10.1203/01.PDR.0000181381.82856.23)
84. Simán CM, Sibley CP, Jones CJ, Turner MA & Greenwood SL 2001 The functional regeneration of syncytiotrophoblast in cultured explants of term placenta. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 280 R1116-R1122.
85. Stanley JL, Andersson IJ, Hirt CJ, Moore L, Dilworth MR, Chade AR, Sibley CP, Davidge ST & Baker PN 2012 Effect of the anti-oxidant tempol on fetal growth in a mouse model of fetal growth restriction. Biology of Reproduction 87 21-28. (doi:10.1095/biolreprod.111.096198)
86. Stanley JL, Andersson IJ, Poudel R, Rueda-Clausen CF, Sibley CP, Davidge ST & Baker PN 2012 Sildenafil citrate rescues fetal growth in the catechol-O-methyl transferase knockout mouse model. Hypertension 59 1021-1028. (doi:10.1161/HYPERTENSIONAHA.111.186270)
87. Swanson AM & David AL 2015 Animal models of fetal growth restriction: considerations for translational medicine. Placenta 36 623-630. (doi:10.1016/j.placenta.2015.03.003)
88. Swanson AM, Rossi CA, Ofir K, Mehta V, Boyd M, Barker H, Ledwozyw A, Vaughan O, Martin J, Zachary I, et al. 2016 Maternal therapy with Ad.VEGF-A165 increases fetal weight at term in a guinea-pig model of fetal growth restriction. Human Gene Therapy 27 997-1007. (doi:10.1089/hum.2016.046)
89. Trapani A, Gonçalves LF, Trapani TF, Franco MJ, Galluzzo RN & Pires MM 2016 Comparison between transdermal nitroglycerin and sildenafil citrate in intrauterine growth restriction: effects on uterine, umbilical and fetal middle cerebral artery pulsatility indices. Ultrasound in Obstetrics and Gynecology 48 61-65. (doi:10.1002/uog.15673)
90. Villanueva-García D, Mota-Rojas D, Hernández-González R, Sánchez-Aparicio P, Alonso-Spilsbury M, Trujillo-Ortega ME, Necoechea RR & Nava-Ocampo AA 2007 A systematic review of experimental and clinical studies of sildenafil citrate for intrauterine growth restriction and pre-term labour. Journal of Obstetrics and Gynaecology 27 255-259. (doi:10.1080/01443610701194978)
91. von Dadelszen P, Dwinnell S, Magee LA, Carleton BC, Gruslin A, Lee B, Lim KI, Liston RM, Miller SP, Rurak D, et al. 2011 Sildenafil citrate therapy for severe early-onset intrauterine growth restriction. BJOG 118 624-628. (doi:10.1111/j.1471-0528.2010.02879.x)
92. Wareing M, Crocker IP, Warren AY, Taggart MJ & Baker PN 2002 Characterization of small arteries isolated from the human placental chorionic plate. Placenta 23 400-409. (doi:10.1053/plac.2002.0825)
93. Wareing M, Myers JE, O'hara M, Kenny LC, Warren AY, Taggart MJ, Skillern L, Machin I & Baker PN 2004 Effects of a phosphodiesterase-5 (PDE5) inhibitor on endothelium-dependent relaxation of myometrial small arteries. American Journal of Obstetrics and Gynecology 190 1283-1290. (doi:10.1016/j.ajog.2003.12.024)
94. Wareing M, Myers JE, O'Hara M & Baker PN 2005 Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction. Journal of Clinical Endocrinology and Metabolism 90 2550-2555. (doi:10.1210/jc.2004-1831)
95. Widdows KL, Panitchob N, Crocker IP, Please CP, Hanson MA, Sibley CP, Johnstone ED, Sengers BG, Lewis RM & Glazier JD 2015 Integration of computational modeling with membrane transport studies reveals new insights into amino acid exchange transport mechanisms. FASEB Journal 29 2583-2594. (doi:10.1096/fj.14-267773)
96. Wyrwoll CS, Noble J, Thomson A, Tesic D, Miller MR, Rog-Zielinska EA, Moran CM, Seckl JR, Chapman KE & Holmes MC 2016 Pravastatin ameliorates placental vascular defects, fetal growth, and cardiac function in a model of glucocorticoid excess. PNAS 113 6265-6270. (doi:10.1073/pnas.1520356113)